Skip to content

Time left to comment:


Posts Tagged ‘MHRA’

UK House of Commons: No Deal Brexit Exposes U.K. to Both Counterfeit Medication and Medication Shortages

In a report published by the House of Commons, experts in the field of prescription medication described a dire situation for medicine safety in the United Kingdom (UK) if a “no-deal” departure from the European Union (EU) happens. The report noted, “Witnesses told us that, without provisions with the EU to continue to exchange data, the UK would be shut out of critical EU data exchanges on pharmacovigilance, falsified medicines and clinical trials.”


“Safe” Country Focus: United Kingdom

As my colleague Thomas Kubic recently noted, most supporters of drug importation have a faulty assumption that developed countries like Canada, Australia, Japan and the 27 members of the European Union (E.U.) are insulated from the global threat of counterfeit drugs. In the coming weeks, we will take a closer look at some of these so-called “safe” countries and illustrate why there is no such thing as a “safe” country when it comes to drug importation.


Counterfeit Insulin Needles Found in the UK

Counterfeit Insulin Needles Found in UK View Larger Map What: A batch of counterfeit insulin pen needles emulating those made by Novo Nordisk were discovered in the United Kingdom. According to the Juvenile Diabetes Research Foundation in England, “the needles were not made by Novo Nordisk, the manufacturer of NovoFine® and do not comply with…


They’re Not Going to Take It

Recognizing the growing threat of the availability of counterfeit drugs worldwide, the Medicines and Healthcare Regulatory Products Agency (MHRA) – Britain's version of the FDA – last week published its first Anti-Counterfeiting Strategy. The strategy sets out the MHRA's approach to combating this threat for the next three years, including the launch of a new 24-hour hotline for reporting suspected counterfeit medicines and devices.

Scroll To Top